Werewolf Therapeutics Inc
NASDAQ:HOWL

Watchlist Manager
Werewolf Therapeutics Inc Logo
Werewolf Therapeutics Inc
NASDAQ:HOWL
Watchlist
Price: 1.28 USD 4.92% Market Closed
Market Cap: 57.4m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

HOWL Price Targets Summary
Werewolf Therapeutics Inc

There are no price targets for HOWL.
HOWL Lowest Forecast
Wall Street Target
Not Available
HOWL Average Forecast
Wall Street Target
Not Available
HOWL Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Werewolf Therapeutics Inc Competitors:
Price Targets
ELDN
Eledon Pharmaceuticals Inc
243% Upside
V
VTGN
VistaGen Therapeutics Inc
420% Upside
VIR
Vir Biotechnology Inc
593% Upside
603392
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
11% Downside
ELDN
Eledon Pharmaceuticals Inc
243% Upside
V
VTGN
VistaGen Therapeutics Inc
420% Upside
VIR
Vir Biotechnology Inc
593% Upside
603392
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
11% Downside
SWTX
SpringWorks Therapeutics Inc
20% Upside
301080
Acrobiosystems Co Ltd
3% Upside
TRDA
Entrada Therapeutics Inc
214% Upside
CRSP
CRISPR Therapeutics AG
127% Upside

Revenue
Forecast

Revenue Estimate
Werewolf Therapeutics Inc

The compound annual growth rate of Werewolf Therapeutics Inc's revenue for the next 3 years is 46%.

N/A
Past Growth
46%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Werewolf Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Werewolf Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-30%
Average Miss
What are analyst estimates?

See Also

Summary
HOWL intrinsic value, competitors valuation, and company profile.
DCF Valuation
HOWL stock valuation using Discount Cash Flow valuation method.
Relative Valuation
HOWL stock valuation using valuation multiples.
Wall Street Estimates
HOWL price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
HOWL stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HOWL's stock price target?
Not Available

HOWL doesn't have any price targets made by Wall Street professionals.

What is Werewolf Therapeutics Inc's Revenue forecast?
Projected CAGR
46%

The compound annual growth rate of Werewolf Therapeutics Inc's revenue for the next 3 years is 46%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 258,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.